EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonists

Amihai Rottenstreich iD, James B Bussel iD

British Journal of Haematology · 2023-12 · 203 (5) · 872-885

DOI: 10.1111/bjh.19161 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 13.10.2023. Verfasst von Amihai Rottenstreich und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, New York, New York, USA. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The introduction of thrombopoietin receptor agonists (TPO‐RAs) led to a paradigm shift in the management of immune thrombocytopenia (ITP). However, TPO‐RAs are not approved for use during pregnancy due to the absence of evidence and concerns for possible effects on the fetus due to their expected transplacental transfer. This comprehensive review examines the safety and efficacy of TPO‐RA in 45 pregnancies of women with ITP (romiplostim n = 22; eltrombopag n = 21; both in the same pregnancy n = 2). Mothers experienced failure of the median of three treatment lines during pregnancy prior to TPO‐RA administration. A platelet response (>30 × 10 9 /L) was seen in 86.7% of cases (including a complete response >100 × 10 9 /L in 66.7%) and was similar between eltrombopag and romiplostim (87.0% and 83.3%, p = 0.99). The maternal safety profile was favourable, with no thromboembolic events encountered. Neonatal thrombocytopenia was noted in one third of cases, with one case of ICH grade 3, and neonatal thrombocytosis was observed in three cases. No other neonatal adverse events attributable to TPO‐RAs were seen. This review suggests that the use of TPO‐RA during pregnancy is associated with a high response rate and appears safe. Nevertheless, TPO‐RA should not be routinely used in pregnancy and should be avoided in the first trimester until further evidence is accumulated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicInfant, NewbornHumansFemalePregnancyReceptors, ThrombopoietinBenzoatesHydrazinesThrombopoietinReceptors, FcRecombinant Fusion ProteinsPyrazoles

Stichwörter der Autor:innen

ITPTPOeltrombopagimmune thrombocytopenic purpurapregnancyromiplostimthrombopoietin receptor agonists

Substanzen

Receptors, ThrombopoietinBenzoatesHydrazinesThrombopoietinReceptors, FcRecombinant Fusion ProteinseltrombopagPyrazoles

Autor:innen und Institutionen

  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, New York, New York, USA.
  • Laboratory of Blood and Vascular Biology, Rockefeller University, New York, New York, USA.
  • Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
  • Division of Hematology/Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA.

ORCID-Profile: Amihai Rottenstreich, James B Bussel

Zitieren

APA

Rottenstreich, A., & Bussel, J. B. (2023). Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonists. British Journal of Haematology, 203(5), 872-885. https://doi.org/10.1111/bjh.19161

Vancouver

Rottenstreich A, Bussel JB. Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonists. British Journal of Haematology. 2023;203(5):872-885. doi:10.1111/bjh.19161

BibTeX
@article{Rottenstreich2023,
  author = {Rottenstreich, Amihai and Bussel, James B},
  title = {Treatment of immune thrombocytopenia during pregnancy with thrombopoietin receptor agonists},
  journal = {British Journal of Haematology},
  year = {2023},
  volume = {203},
  number = {5},
  pages = {872--885},
  doi = {10.1111/bjh.19161}
}
Kostenlos starten →